FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2900799599> ?p ?o ?g. }

• W2900799599 endingPage "e194" @default.
• W2900799599 startingPage "e186" @default.
• W2900799599 abstract "Background Molecular characterization of non–small-cell lung cancer (NSCLC), defined predictive and druggable mutations that greatly modified patient prognoses. The most frequent driver mutations detected in NSCLC are epidermal growth factor receptor (EGFR) mutations, accounting for approximately 90% of exon 19 deletions and exon 21 point mutations. The other EGFR mutations are classified as uncommon or nonclassical and include exon 18 point mutations, exon 20 insertions, and combined mutations, which present different sensitivity to tyrosine kinase inhibitor (TKI) targeting. Patients and Methods We collected data from EGFR TKI-naive patients with metastatic NSCLC, harboring EGFR exon 18 mutations and EGFR combined mutations treated with first- or second-generation EGFR TKIs. Efficacy end points were evaluated considering the activity of EGFR TKIs in exon 18 versus double-mutation EGFR groups. Results Eighty-eight patients harboring uncommon EGFR mutations were evaluated in our analysis, and subdivided into 2 group: complex mutations (cohort A = 46 patients) and double mutations in exon 18 (cohort B = 42 patients). The results showed a median progression-free survival of 8.3 versus 12.3 months (hazard ratio [HR], 0.65; P = .06) and a median overall survival of 17.0 versus 31.0 months (HR, 0.62, P = .04) favoring the EGFR combination group. Within the combination group, no detrimental effect was associated with exon 20 mutations. Conclusion Our study confirmed that EGFR exon 18 and combination mutations might be considered potentially sensitive uncommon mutations, with a similar survival compared with the well known common EGFR mutations. Comparative analysis showed that patients with complex mutations achieved longer survival compared with the exon 18 group, without correlation with the presence of exon 20 mutations." @default.
• W2900799599 created "2018-11-29" @default.
• W2900799599 creator A5001928949 @default.
• W2900799599 creator A5003664573 @default.
• W2900799599 creator A5003880441 @default.
• W2900799599 creator A5011139663 @default.
• W2900799599 creator A5016783216 @default.
• W2900799599 creator A5021264126 @default.
• W2900799599 creator A5032833091 @default.
• W2900799599 creator A5033247793 @default.
• W2900799599 creator A5052032389 @default.
• W2900799599 creator A5053651576 @default.
• W2900799599 creator A5057636197 @default.
• W2900799599 creator A5059919842 @default.
• W2900799599 creator A5063424146 @default.
• W2900799599 creator A5064162399 @default.
• W2900799599 creator A5064646828 @default.
• W2900799599 creator A5067754025 @default.
• W2900799599 creator A5071783009 @default.
• W2900799599 creator A5072550519 @default.
• W2900799599 creator A5080816334 @default.
• W2900799599 creator A5086247944 @default.
• W2900799599 creator A5091886023 @default.
• W2900799599 date "2019-03-01" @default.
• W2900799599 modified "2023-10-18" @default.
• W2900799599 title "Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations" @default.
• W2900799599 cites W2000082608 @default.
• W2900799599 cites W2006505028 @default.
• W2900799599 cites W2014993624 @default.
• W2900799599 cites W2036926586 @default.
• W2900799599 cites W2040299716 @default.
• W2900799599 cites W2043696829 @default.
• W2900799599 cites W2051749558 @default.
• W2900799599 cites W2053603900 @default.
• W2900799599 cites W2062629045 @default.
• W2900799599 cites W2096198395 @default.
• W2900799599 cites W2111662961 @default.
• W2900799599 cites W2113521542 @default.
• W2900799599 cites W2129360604 @default.
• W2900799599 cites W2132157071 @default.
• W2900799599 cites W2133149289 @default.
• W2900799599 cites W2139236349 @default.
• W2900799599 cites W2139804581 @default.
• W2900799599 cites W2149900426 @default.
• W2900799599 cites W2154130790 @default.
• W2900799599 cites W2161821474 @default.
• W2900799599 cites W2166084034 @default.
• W2900799599 cites W2171139285 @default.
• W2900799599 cites W2171916712 @default.
• W2900799599 cites W2210071992 @default.
• W2900799599 cites W2283037401 @default.
• W2900799599 cites W2416016548 @default.
• W2900799599 cites W2566863750 @default.
• W2900799599 cites W2609723037 @default.
• W2900799599 cites W2621269107 @default.
• W2900799599 cites W2768053061 @default.
• W2900799599 cites W2773258191 @default.
• W2900799599 cites W3094892024 @default.
• W2900799599 cites W4210992155 @default.
• W2900799599 cites W4244120980 @default.
• W2900799599 doi "https://doi.org/10.1016/j.cllc.2018.11.005" @default.
• W2900799599 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30563752" @default.
• W2900799599 hasPublicationYear "2019" @default.
• W2900799599 type Work @default.
• W2900799599 sameAs 2900799599 @default.
• W2900799599 citedByCount "37" @default.
• W2900799599 countsByYear W29007995992019 @default.
• W2900799599 countsByYear W29007995992020 @default.
• W2900799599 countsByYear W29007995992021 @default.
• W2900799599 countsByYear W29007995992022 @default.
• W2900799599 countsByYear W29007995992023 @default.
• W2900799599 crossrefType "journal-article" @default.
• W2900799599 hasAuthorship W2900799599A5001928949 @default.
• W2900799599 hasAuthorship W2900799599A5003664573 @default.
• W2900799599 hasAuthorship W2900799599A5003880441 @default.
• W2900799599 hasAuthorship W2900799599A5011139663 @default.
• W2900799599 hasAuthorship W2900799599A5016783216 @default.
• W2900799599 hasAuthorship W2900799599A5021264126 @default.
• W2900799599 hasAuthorship W2900799599A5032833091 @default.
• W2900799599 hasAuthorship W2900799599A5033247793 @default.
• W2900799599 hasAuthorship W2900799599A5052032389 @default.
• W2900799599 hasAuthorship W2900799599A5053651576 @default.
• W2900799599 hasAuthorship W2900799599A5057636197 @default.
• W2900799599 hasAuthorship W2900799599A5059919842 @default.
• W2900799599 hasAuthorship W2900799599A5063424146 @default.
• W2900799599 hasAuthorship W2900799599A5064162399 @default.
• W2900799599 hasAuthorship W2900799599A5064646828 @default.
• W2900799599 hasAuthorship W2900799599A5067754025 @default.
• W2900799599 hasAuthorship W2900799599A5071783009 @default.
• W2900799599 hasAuthorship W2900799599A5072550519 @default.
• W2900799599 hasAuthorship W2900799599A5080816334 @default.
• W2900799599 hasAuthorship W2900799599A5086247944 @default.
• W2900799599 hasAuthorship W2900799599A5091886023 @default.
• W2900799599 hasConcept C104317684 @default.
• W2900799599 hasConcept C121608353 @default.
• W2900799599 hasConcept C126322002 @default.
• W2900799599 hasConcept C143998085 @default.
• W2900799599 hasConcept C176944494 @default.

• next